The_DT
cellular_JJ
oncogene_NN
c-myb_NN
can_MD
interact_VB
synergistically_RB
with_IN
the_DT
Epstein-Barr_JJ
virus_NN
BZLF1_NN
transactivator_NN
in_IN
lymphoid_JJ
cells_NNS
._.

Regulation_NN
of_IN
replicative_JJ
functions_NNS
in_IN
the_DT
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
genome_NN
is_VBZ
mediated_VBN
through_IN
activation_NN
of_IN
a_DT
virally_RB
encoded_VBN
transcription_NN
factor_NN
,_,
Z_NN
-LRB-_-LRB-
BZLF1_NN
-RRB-_-RRB-
._.

We_PRP
have_VBP
shown_VBN
that_IN
the_DT
Z_NN
gene_NN
product_NN
,_,
which_WDT
binds_VBZ
to_TO
AP-1_NN
sites_NNS
as_IN
a_DT
homodimer_NN
and_CC
has_VBZ
sequence_NN
similarity_NN
to_TO
c-Fos_NN
,_,
can_MD
efficiently_RB
activate_VB
the_DT
EBV_NN
early_JJ
promoter_NN
,_,
BMRF1_NN
,_,
in_IN
certain_JJ
cell_NN
types_NNS
-LRB-_-LRB-
i.e._FW
,_,
HeLa_NN
cells_NNS
-RRB-_-RRB-
but_CC
not_RB
others_NNS
-LRB-_-LRB-
i.e._FW
,_,
Jurkat_NN
cells_NNS
-RRB-_-RRB-
._.

Here_RB
we_PRP
demonstrate_VBP
that_IN
the_DT
c-myb_NN
proto-oncogene_NN
product_NN
,_,
which_WDT
is_VBZ
itself_PRP
a_DT
DNA-binding_JJ
protein_NN
and_CC
transcriptional_JJ
transactivator_NN
,_,
can_MD
interact_VB
synergistically_RB
with_IN
Z_NN
in_IN
activating_VBG
the_DT
BMRF1_NN
promoter_NN
in_IN
Jurkat_NN
cells_NNS
-LRB-_-LRB-
a_DT
T-cell_NN
line_NN
-RRB-_-RRB-
or_CC
Raji_NN
cells_NNS
-LRB-_-LRB-
an_DT
EBV-positive_JJ
B-cell_NN
-RRB-_-RRB-
,_,
whereas_IN
the_DT
c-myb_NN
gene_NN
product_NN
by_IN
itself_PRP
has_VBZ
little_JJ
effect_NN
._.

The_DT
simian_JJ
virus_NN
40_CD
early_JJ
promoter_NN
is_VBZ
also_RB
synergistically_RB
activated_VBN
by_IN
the_DT
Z\/c-myb_NN
combination_NN
._.

Synergistic_JJ
transactivation_NN
of_IN
the_DT
BMRF1_NN
promoter_NN
by_IN
the_DT
Z\/c-myb_NN
combination_NN
appears_VBZ
to_TO
involve_VB
direct_JJ
binding_NN
by_IN
the_DT
Z_NN
protein_NN
but_CC
not_RB
the_DT
c-myb_NN
protein_NN
._.

A_DT
30-bp_JJ
sequence_NN
in_IN
the_DT
BMRF1_NN
promoter_NN
which_WDT
contains_VBZ
a_DT
Z_NN
binding_NN
site_NN
-LRB-_-LRB-
a_DT
consensus_NN
AP-1_NN
site_NN
-RRB-_-RRB-
is_VBZ
sufficient_JJ
to_TO
transfer_VB
high-level_JJ
lymphoid-specific_JJ
responsiveness_NN
to_TO
the_DT
Z\/c-myb_NN
combination_NN
to_TO
a_DT
heterologous_JJ
promoter_NN
._.

That_IN
the_DT
c-myb_NN
oncogene_NN
product_NN
can_MD
interact_VB
synergistically_RB
with_IN
an_DT
EBV-encoded_JJ
member_NN
of_IN
the_DT
leucine_NN
zipper_NN
protein_NN
family_NN
suggests_VBZ
c-myb_NN
is_VBZ
likely_JJ
to_TO
engage_VB
in_IN
similar_JJ
interactions_NNS
with_IN
cellularly_RB
encoded_VBN
transcription_NN
factors_NNS
._.

